ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,926Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 2429

$568K Total Retail Price of All Prescriptions

Rank: 206 out of 2429

224 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 224 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 583 543 1 1
FUROSEMIDE 400 381 2 5
METOPROLOL TARTRATE 391 378 3 9
AMLODIPINE BESYLATE 338 307 4 4
DONEPEZIL HCL 332 318 5 26
LISINOPRIL 308 283 6 2
FAMOTIDINE 276 243 7 42
HEPARIN SODIUM 252 219 8 116
ENALAPRIL MALEATE 230 211 9 32
OMEPRAZOLE 221 212 10 7
METFORMIN HCL 221 182 10 8
NAMENDA 204 204 12 35
RISPERIDONE 202 201 13 52
WARFARIN SODIUM 180 179 14 11
NIFEDIPINE ER 178 155 15 76
HYDRALAZINE HCL 174 163 16 81
IBUPROFEN 166 142 17 57
POTASSIUM CHLORIDE 154 126 18 14
HYDROCHLOROTHIAZIDE 143 130 19 10
TRAMADOL HCL 140 136 20 17
CARVEDILOL 132 110 21 21
GLIPIZIDE 130 103 22 47
CLONIDINE HCL 129 118 23 68
ISOSORBIDE MONONITRATE ER 119 119 24 55
LEVOTHYROXINE SODIUM 114 106 25 3
TAMSULOSIN HCL 113 105 26 29
KLOR-CON M20 107 107 27 60
CLOPIDOGREL 103 90 28 31
DIGOXIN 101 94 29 43
LOSARTAN POTASSIUM 94 90 30 22
GABAPENTIN 89 89 31 18
ATORVASTATIN CALCIUM 85 44 32 13
CITALOPRAM HBR 85 79 32 19
PHENYTOIN SODIUM EXTENDED 82 58 34 108
ALLOPURINOL 79 79 35 33
PLAVIX 79 73 35 44
DIVALPROEX SODIUM 78 54 37 78
DIOVAN 77 73 38 36
NAPROXEN 75 70 39 75
BENZTROPINE MESYLATE 73 58 R 40 110
SANTYL 73 42 40 189
ESCITALOPRAM OXALATE 71 64 42 74
PANTOPRAZOLE SODIUM 69 45 43 34
NOVOLIN R 65 51 44 196
OXYBUTYNIN CHLORIDE ER 60 60 45 79
SERTRALINE HCL 58 49 46 23
LEVETIRACETAM 58 50 46 91
ATENOLOL 56 56 48 15
PHENYTOIN 51 51 49 236
ABILIFY 50 50 50 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.